Skip to content

688428.SH

InnoCare Pharma Ltd.

SSE · CN

CNY 27.54
−6.96%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue2.8B2.4B1.0B738.5M625.4M
Cost of Revenue256.2M191.1M138.4M128.4M143.4M
Gross Profit2.5B2.2B871.0M610.1M482.0M
Operating Expenses
R&D Expense979.6M951.6M814.6M757.3M648.7M
SG&A Expense199.3M
General & Admin Expense139.2M179.2M168.5M184.1M175.0M
Selling & Marketing Expense454.7M580.0M420.0M366.9M438.6M
Other Expenses5.2M
Total Operating Expenses1.7B1.6B1.3B1.2B1.4B
Cost and Expenses2.0B1.8B1.5B1.4B1.6B
Operating Income (EBIT)864.6M655.5M(451.0M)(651.2M)(893.2M)
Non-Operating
Interest Income37.3M
Interest Expense15.1M
Net Interest Income22.2M
Other Non-Op Income/Expense67.9M
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)932.9M655.7M(452.6M)(644.2M)(893.7M)
Income Tax Expense14.0M11.6M262.7K1.4M
Bottom Line
Net Income918.3M642.5M(440.6M)(631.3M)(886.6M)
Earnings from Cont. Ops918.9M644.2M(452.9M)(645.6M)(893.7M)
Earnings from Discont. Ops
Bottom Line Net Income918.3M642.5M(440.6M)(631.3M)(886.6M)
Per Share
Basic EPSCN¥0.08CN¥0.38(CN¥0.26)(CN¥0.37)(CN¥0.60)
Diluted EPSCN¥0.08CN¥0.38(CN¥0.26)(CN¥0.37)(CN¥0.60)
Revenue Per ShareCN¥1.57
Shares
Basic Shares Outstanding1.8B
Diluted Shares Outstanding1.8B
Profitability Metrics
EBITDA102.7M744.0M(372.5M)(580.1M)(844.9M)
D&A29.0M88.5M78.6M71.1M48.3M
EBIT73.8M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026